Professor Ilias Goranitis is the inaugural Head of the Economics of Genomics and Precision Medicine Unit and Deputy Head of Melbourne Health Economics at the University of Melbourne. He led the Economics program of Australian Genomics. His research assesses the value and cost-effectiveness of genomic medicine, and his findings supported public funding of genomic testing for rare conditions in Australia and informed international guidelines. He led the health economics evidence reviews informing Cancer Australia's National Framework for Genomics in Cancer Control and a WHO investment case on human genomics. He has led the health economics work of a AU$120+ million research portfolio and has published 100+ peer-reviewed articles. The impact of his work has been recognised through the 2024 Deeble-Scotton Policy Impact Award and a Dame Kate Campbell Fellowship.